Cencora | COR - Gross Profit On Sales

Stock Price
355.62
Daily Change
3.46 0.98%
Monthly
4.47%
Yearly
43.46%
Q1 Forecast
348.16

Cencora reported $2.96B in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
Ambu A/S DKK 947M 68M Dec/2025
Amplifon EUR 103.17M 44.14M Sep/2025
Apollo Hospitals Enterprise Ltd INR 26.64B 6.6B Mar/2025
Avanos Medical USD 86M 6.1M Sep/2025
Brookdale Senior Living USD 210.85M 7.15M Sep/2025
Cencora USD 2.96B 48.98M Sep/2025
Convatec Group USD 660.5M 348.95M Dec/2024
Diasorin EUR 181.08M 19.92M Sep/2025
Encompass Health USD 1.41B 786M Sep/2025
Enovis USD 328.91M 12.59M Sep/2025
GE HealthCare Technologies USD 1.99B 4M Sep/2025
Gulf Medical Proj AED 46.22M 8.48M Mar/2025
Hoya 61.95B 117.57B Sep/2025
Med Life RON 636.25M 40.3M Jun/2025
Oriola-kd EUR 40.2M 2.1M Sep/2025
Rede D'or Sao Luiz BRL 3.36B 441.22M Sep/2025
Siemens Healthineers EUR 2.08B 299M Dec/2025
Solventum Corp USD 1.14B 40M Sep/2025
Sonova Holding CHF 1.28B 205.2M Dec/2025
Supermax Corporation Bhd MYR -143.15M 161.11M Sep/2025
Zimmer Biomet Holdings USD 1.27B 58.9M Sep/2025